Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN112279891A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112279891A details a novel solid-phase synthesis for Triptorelin using piperazine, offering high purity crude product and significant supply chain advantages for pharmaceutical manufacturers.